The conservation of this public-like TCR motif across all but 1 donor we studied and the unusual, near ubiquitous, expression of the CD8-αβ isoform defines CAITs as a new T cell subset and suggests that they respond to a common MR1-restricted ligand on the surface of cancer cells. The gene discussed is CD8A; the disease is cancer.